Tan, Shawn Pei Feng
35  results:
Search for persons X
?
 
?
2

Mechanistic Middle-Out Physiologically Based Toxicokinetic ..:

Lin, Jieying ; Chin, Sheng Yuan ; Tan, Shawn Pei Feng...
Environmental Science & Technology.  57 (2023)  17 - p. 6825-6834 , 2023
 
?
 
?
 
?
7

Development of 4-Pyridoxic Acid PBPK Model to Support Bioma..:

Tan, Shawn pei feng ; Willemin, Marie‐emilie ; Snoeys, Jan...
Tan , S P F , Willemin , M , Snoeys , J , Shen , H , Rostami‐hodjegan , A , Scotcher , D & Galetin , A 2023 , ' Development of 4-Pyridoxic Acid PBPK Model to Support Biomarker- Informed Evaluation of OAT1/3 Inhibition and Effect of Chronic Kidney Disease ' , Clinical Pharmacology & Therapeutics . https://doi.org/10.1002/cpt.3029.  , 2023
 
?
9

Effect of chronic kidney disease on the renal secretion via..:

Tan, Shawn Pei Feng ; Scotcher, Daniel ; Rostami‐hodjegan, Amin.
Tan , S P F , Scotcher , D , Rostami‐hodjegan , A & Galetin , A 2022 , ' Effect of chronic kidney disease on the renal secretion via organic anion transporters (OAT)1/3: Implications for PBPK modelling and dose adjustment ' , Clinical Pharmacology & Therapeutics . https://doi.org/10.1002/cpt.2642.  , 2022
 
?
10

Predicting human tissue exposures to xenobiotics using a bo..:

Tan, Pei Feng Shawn
Tan , P F S 2021 , ' Predicting human tissue exposures to xenobiotics using a bottom-up physiologically-based biokinetic model ' , ALTEX . https://doi.org/10.14573/altex.2007151.  , 2021
 
?
11

Physiologically‐Based Pharmacokinetic Modeling to Predict t..:

Tan, Pei Feng Shawn
Tan , P F S 2020 , ' Physiologically‐Based Pharmacokinetic Modeling to Predict the Clinical Efficacy of the Coadministration of Lopinavir and Ritonavir against SARS‐CoV‐2 ' , Clinical Pharmacology & Therapeutics , vol. 108 , no. 6 , pp. 1176-1184 . https://doi.org/10.1002/cpt.2014.  , 2020
 
?
14

A genome-wide association analysis implicates SOX6 as a can..:

Tan, LiJun ; Liu, Rong ; Lei, ShuFeng...
Science China Life Sciences.  53 (2010)  9 - p. 1065-1072 , 2010
 
1-15